Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors.

We have evaluated the effect of in vivo Campath-1G on engraftment and GVHD in 23 patients with severe aplastic anaemia transplanted from HLA-identical sibling donors. In 14 patients Campath 1g was given pre-transplant for up to 9 days in an attempt to overcome graft rejection (group 1). In nine pati...

ver descrição completa

Detalhes bibliográficos
Principais autores: Hamblin, M, Marsh, J, Lawler, M, McCann, SR, Wickham, N, Dunlop, L, Ball, S, Davies, E, Hale, G, Waldmann, H, Gordon-Smith, E
Formato: Journal article
Idioma:English
Publicado em: 1996